Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 478


Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.

Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, Hutchinson P, Steketee RW.

Lancet Infect Dis. 2012 Dec;12(12):942-9. doi: 10.1016/S1473-3099(12)70222-0. Epub 2012 Sep 18. Review.


Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya.

Hill J, Dellicour S, Bruce J, Ouma P, Smedley J, Otieno P, Ombock M, Kariuki S, Desai M, Hamel MJ, ter Kuile FO, Webster J.

PLoS One. 2013 Jun 14;8(6):e64913. doi: 10.1371/journal.pone.0064913. Print 2013.


Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.

Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, ter Kuile FO, Meshnick SR, Rogerson SJ.

Clin Infect Dis. 2012 Jul;55(1):42-50. doi: 10.1093/cid/cis301. Epub 2012 Mar 22.


Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.

Hommerich L, von Oertzen C, Bedu-Addo G, Holmberg V, Acquah PA, Eggelte TA, Bienzle U, Mockenhaupt FP.

Malar J. 2007 Nov 8;6:144.


Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.

Olliaro PL, Delenne H, Cisse M, Badiane M, Olliaro A, Vaillant M, Brasseur P.

Malar J. 2008 Nov 7;7:234. doi: 10.1186/1475-2875-7-234.


Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.

Walker PG, Floyd J, Ter Kuile F, Cairns M.

PLoS Med. 2017 Feb 28;14(2):e1002243. doi: 10.1371/journal.pmed.1002243. eCollection 2017 Feb.


From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy.

Crawley J, Hill J, Yartey J, Robalo M, Serufilira A, Ba-Nguz A, Roman E, Palmer A, Asamoa K, Steketee R.

Lancet Infect Dis. 2007 Feb;7(2):145-55. Review.


Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.

Filler SJ, Kazembe P, Thigpen M, Macheso A, Parise ME, Newman RD, Steketee RW, Hamel M.

J Infect Dis. 2006 Aug 1;194(3):286-93. Epub 2006 Jun 20.


Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.

Sirima SB, Cotte AH, Konaté A, Moran AC, Asamoa K, Bougouma EC, Diarra A, Ouédraogo A, Parise ME, Newman RD.

Am J Trop Med Hyg. 2006 Aug;75(2):205-11.


Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009-11.

van Eijk AM, Hill J, Larsen DA, Webster J, Steketee RW, Eisele TP, ter Kuile FO.

Lancet Infect Dis. 2013 Dec;13(12):1029-42. doi: 10.1016/S1473-3099(13)70199-3. Epub 2013 Sep 18. Review.


Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.

Fernandes S, Sicuri E, Kayentao K, van Eijk AM, Hill J, Webster J, Were V, Akazili J, Madanitsa M, ter Kuile FO, Hanson K.

Lancet Glob Health. 2015 Mar;3(3):e143-53. doi: 10.1016/S2214-109X(14)70385-7.


Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.

Braun V, Rempis E, Schnack A, Decker S, Rubaihayo J, Tumwesigye NM, Theuring S, Harms G, Busingye P, Mockenhaupt FP.

Malar J. 2015 Sep 26;14:372. doi: 10.1186/s12936-015-0909-7.


Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.

Mace KE, Chalwe V, Katalenich BL, Nambozi M, Mubikayi L, Mulele CK, Wiegand RE, Filler SJ, Kamuliwo M, Craig AS, Tan KR.

Malar J. 2015 Feb 7;14:69. doi: 10.1186/s12936-015-0576-8.


Malaria in pregnant women in an area with sustained high coverage of insecticide-treated bed nets.

Kabanywanyi AM, Macarthur JR, Stolk WA, Habbema JD, Mshinda H, Bloland PB, Abdulla S, Kachur SP.

Malar J. 2008 Jul 21;7:133. doi: 10.1186/1475-2875-7-133.


The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes.

Serra-Casas E, Menéndez C, Bardají A, Quintó L, Dobaño C, Sigauque B, Jiménez A, Mandomando I, Chauhan VS, Chitnis CE, Alonso PL, Mayor A.

J Infect Dis. 2010 Jan 1;201(1):123-31. doi: 10.1086/648595.


Clinical malaria among pregnant women on combined insecticide treated nets (ITNs) and intermittent preventive treatment (IPTp) with sulphadoxine-pyrimethamine in Yaounde, Cameroon.

Mbu RE, Takang WA, Fouedjio HJ, Fouelifack FY, Tumasang FN, Tonye R.

BMC Womens Health. 2014 May 16;14:68. doi: 10.1186/1472-6874-14-68.


Weighing for results: assessing the effect of IPTp.

Gutman J, Eckert E, Mangiaterra V, Bardají A, Aponte JJ, Menéndez C, Nahlen B, Slutsker L.

Lancet Infect Dis. 2013 Apr;13(4):292. doi: 10.1016/S1473-3099(13)70013-6. No abstract available.


Utilisation of malaria preventive measures during pregnancy and birth outcomes in Ibadan, Nigeria.

Tongo OO, Orimadegun AE, Akinyinka OO.

BMC Pregnancy Childbirth. 2011 Aug 18;11:60. doi: 10.1186/1471-2393-11-60.

Supplemental Content

Support Center